Real‐world data on the effectiveness, safety and drug survival of dupilumab: an analysis from the TREATgermany registry. (1st December 2022)

• Record Type: Journal Article
• Authors: Stölzl, Dora; Sander, Nicole; Heratizadeh, Annice; Haufe, Eva; Harder, Inken; Abraham, Susanne; Heinrich, Luise; Kleinheinz, Andreas; Wollenberg, Andreas; Weisshaar, Elke; Schäkel, Knut; Ertner, Konstantin; Wiemers, Franca; Wildberger, Julia; Worm, Margitta; von Kiedrowski, Ralph; Effendy, Isaak; Asmussen, Andrea; Augustin, Matthias; Pawlak, Mario; Sticherling, Michael; Zink, Alexander; Hilgers, Melanie; Handrick, Christiane; Quist, Sven; Schwarz, Beate; Staubach‐Renz, Petra; Bell, Magnus; Hong‐Weldemann, Sun‐Hei; Homey, Bernhard; Brücher, Jens‐Joachim; Schmitt, Jochen; Werfel, Thomas; Weidinger, Stephan;
• Is Part Of: British journal of dermatology. Volume 187:Number 6(2022)
• Page Start: 1022
• Page End: 1024
• Publication Date: 2022-12-01
• Subjects: Dermatology -- Periodicals; Skin -- Diseases -- Periodicals; 616.5
• DOI: 10.1111/bjd.21794
• Languages: English
• ISSNs: 0007-0963

Abstract

Abstract: This interim analysis from the atopic dermatitis registry TREATgermany shows robust long‐term efficacy, favourable safety and high persistence of dupilumab under real life conditions.